Biopharma Group has sold Crowthorne Group to Normec Group
Biopharma Group has sold Crowthorne Group Limited to Normec Group.
Crowthorne Group is the largest independent provider of clean air and containment services in the UK and Ireland, with growing operations in Asia and the Middle East. Crowthorne offers servicing, validation, testing and certification services to the clean air industry. Its client base includes some of the most recognizable names in the pharma, biopharma and healthcare sectors, alongside a number of global NGOs.
Normec is the holding company of the Normec Group. The company is active in the field of testing, inspecting, certification and compliance (TICC) across Europe. It assesses and supports the quality and safety of materials, systems and products by conducting independent audits, tests and inspections based on accredited methods. Normec operates in the life safety and environment, and food and agriculture segments.
Biopharma Group has several dedicated divisions covering the UK, France, Ireland and US. Its aim is to meet the needs of its customers’ projects appropriate to the size and stage by augmenting their in-house expertise whether to buy equipment, a single cycle run/analysis or a full formulation development program.
Oaklins Evelyn Partners, based in the UK, acted as lead advisor to Crowthorne in this transaction. The sale adds to Oaklins’ recent transaction experience in the TICC sector.
Andrew Cowen
Chairman, Biopharma Group
Contáctese con el equipo de la transacción
Transacciones relacionadas
Mark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Conozca másGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Conozca másDaqui pra Fora has sold a stake in the company to Grupo CI
Grupo CI has acquired a stake in Daqui pra Fora.
Conozca más